🔎 Trials Near Me

Home › Respiratory Distress Syndrome › NCT06701669

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

RecruitingPhase 2

Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

The following inclusion criteria are in addition to the exclusion criteria specified in the Master Protocol NCT06703073:

* ARDS Severity of moderate or severe based on PaO2/FiO2 or SpO2/FiO2 assessment at the time of randomization.

Exclusion Criteria:

The following exclusion criteria are in addition to the exclusion criteria specified in the Master Protocol NCT06703073.

* Participant has a known allergy or known hypersensitivity to paridiprubart or its excipients, including polysorbate 80
* Participant with established cirrhosis and a modified Child-Pugh Score of 12 or greater

About the study

This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design.

Cohort B: Participants will be randomized to receive either a placebo or paridiprubart.

This record describes the default procedures and analyses for Cohort B. Please see NCT06703073 for information on the BP-ARDS-P2-001 Master Protocol.

What is being tested

Sponsor: PPD Development, LP · Participants: 200 · Started: Jun 10, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06701669

Locations in the U.S.

AlabamaUniversity of Alabama Hospital, Birmingham (Not yet recruiting)
CaliforniaCommunity Regional Medical Center, Fresno
Long Beach Memorial Medical Center, Long Beach
University of California Irvine Medical Center, Orange
University of California Davis Medical Center - Pulmonary Medicine, Sacramento
Stanford Medical Center, Stanford
ColoradoDenver Health Hospital and Authority, Denver
District of ColumbiaMedStar Washington Hospital Center, Washington D.C.
FloridaNova Clinical Research, Bradenton
North Florida / South Georgia Veterans Health System, Gainesville
Sarasota Memorial Hospital, Sarasota
IdahoSt. Luke's Boise Medical Center, Boise
IllinoisNorthshore University Healthsystem Research Institute, Evanston (Not yet recruiting)
OSF Saint Francis Medical Center-, Peoria
MassachusettsTufts Medical Center, Boston (Not yet recruiting)
Lahey Hospital and Medical Center, Burlington
MichiganUniversity of Michigan Hospital, Ann Arbor
Henry Ford Health Hospital, Detroit
MinnesotaMayo Clinic, Rochester
New JerseyRobert Wood Johnson Medical School, New Brunswick
New YorkMemorial Sloan Kettering Cancer Center, New York (Not yet recruiting)
Weill Cornell Medical College, New York (Not yet recruiting)
Montefiore Hospital - Moses Campus, The Bronx
Westchester Medical Center, Valhalla (Not yet recruiting)
North CarolinaUniversity of North Carolina at Chapel Hill, Chapel Hill
Duke Lung Transplant Clinic - Clinic 2F/2G - PPDS, Durham (Not yet recruiting)
Durham VA Medical Center, Durham
OhioCleveland Clinic, Cleveland (Not yet recruiting)
University Hospitals Cleveland Medical Center, Cleveland (Not yet recruiting)
Mercy Health - St. Vincent Medical Center, Toledo
OklahomaThe University of Oklahoma Health Sciences Center, Oklahoma City
OregonOregon Health and Science University, Portland
South CarolinaMedical University of South Carolina (MUSC), Charleston
TennesseeVanderbilt University Medical Center, Nashville
TexasBaylor All Saints Medical Center, Fort Worth
Baylor St Luke's Medical Center, Houston (Not yet recruiting)
Houston Methodist Hospital, Houston (Not yet recruiting)
UtahIntermountain Medical Center, Murray
VirginiaUniversity of Virginia Health System, Charlottesville (Not yet recruiting)
WashingtonSwedish Medical Center, Seattle

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.